| Type 1 Diabetes Mellitus |
1 |
1 |
| Lipids Management |
0 |
0.82 |
| Cardiovascular Risk Management |
0 |
0.99 |
| Body Mass Index |
0 |
0.66 |
| LDL Cholesterol |
0 |
0.42 |
| Coronary Artery Disease (CAD) |
0 |
0.34 |
| Dyslipidemia |
0 |
0.33 |
| Coronary Artery Calcification |
0 |
0.3 |
| Angiography |
0 |
0.25 |
| Calcium |
0 |
0.25 |
| Hypertension |
0 |
0.25 |
| Lipoproteins |
0 |
0.25 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
0.23 |
| Myocardial Infarction (MI) |
0 |
0.22 |
| Coronary Atherosclerosis |
0 |
0.21 |
| Heart Failure (HF) |
0 |
0.21 |
| Obesity |
0 |
0.21 |
| Type 2 Diabetes Mellitus |
0 |
0.21 |
| Atherosclerosis |
0 |
0.2 |
| Artery |
0 |
0.16 |
| Cardiovascular disease |
0 |
0.16 |
| France |
0 |
0.16 |
| Hyperglycemia |
0 |
0.16 |
| Triglycerides |
0 |
0.16 |
| Cardiovascular Imaging |
0 |
0.13 |
| Match |
0 |
0.13 |
| Acute Myocardial Infarction (MI) |
0 |
0.12 |
| Carotid Ultrasound |
0 |
0.12 |
| Osteoarthritis |
0 |
0.1 |
| B-Type Natriuretic Peptide |
0 |
0.08 |
| Biomarker |
0 |
0.08 |
| Blood |
0 |
0.08 |
| Cancer |
0 |
0.08 |
| Endocrinology |
0 |
0.08 |
| Environmental Medicine |
0 |
0.08 |
| Europe |
0 |
0.08 |
| Hypoglycemia |
0 |
0.08 |
| Infarction |
0 |
0.08 |
| Insulin Pump |
0 |
0.08 |
| Metabolism |
0 |
0.08 |
| Prognosis |
0 |
0.08 |
| Receptors |
0 |
0.08 |
| Statins |
0 |
0.08 |
| Stenosis |
0 |
0.08 |
| Students |
0 |
0.08 |
| Ultrasonography |
0 |
0.08 |
| Young Adult |
0 |
0.08 |
| Acute Coronary Syndrome |
0 |
0.07 |
| Weight Management |
0 |
0.07 |
| Medical Life |
0 |
0.06 |